113 related articles for article (PubMed ID: 309866)
41. Novel tumor-specific antigen(s) response observed in a syngeneic lymphoma-bearing host.
Manson LA
Cancer Detect Prev Suppl; 1987; 1():111-20. PubMed ID: 3121177
[TBL] [Abstract][Full Text] [Related]
42. Transfer of immunity by transfer of bone marrow cells: a requirement for T lymphocytes and sensitivity to cyclophosphamide.
Marusić M
Exp Hematol; 1978 Oct; 6(9):725-37. PubMed ID: 361429
[TBL] [Abstract][Full Text] [Related]
43. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
Ishimoto A; Ito Y
Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
[No Abstract] [Full Text] [Related]
44. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. II. Infections of B and T cells with Friend virus complex indiffusion chambers and in vitro: effect of polyclonal mitogens.
Cerny J; Hensgen PA; Fistel SH; Demler LM
Int J Cancer; 1976 Aug; 18(2):189-96. PubMed ID: 1085288
[TBL] [Abstract][Full Text] [Related]
45. Production of BSF-1 during an in vivo, T-dependent immune response.
Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
[TBL] [Abstract][Full Text] [Related]
46. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. II. Characterization of the cell populations involved in its production and release.
Hollander N; Iskov N; Segal S; Feldman M
Int J Cancer; 1978 Oct; 22(4):471-8. PubMed ID: 359491
[No Abstract] [Full Text] [Related]
47. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.
Herberman RB; Nunn ME; Holden HT; Lavrin DH
Int J Cancer; 1975 Aug; 16(2):230-9. PubMed ID: 1080480
[TBL] [Abstract][Full Text] [Related]
48. Differences in the phenotypes of cells mediating anti-tumour immunity at various stages of tumour progression in mice.
Dent LA; Spencer LK; Attridge S; Finlay-Jones JJ
Immunol Cell Biol; 1989 Dec; 67 ( Pt 6)():403-12. PubMed ID: 2696727
[TBL] [Abstract][Full Text] [Related]
49. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
50. Rosette forming cells in the spleens of mice with lymphoid and myeloid leukemia.
Gabrilovac J; Boranić M
Exp Hematol; 1977 Jan; 5(1):13-8. PubMed ID: 319009
[TBL] [Abstract][Full Text] [Related]
51. Conversion of a tolerogenic to an immunogenic signal by P388AD.2 cells, a lymphoid dendritic cell-like tumor line.
Phipps RP; Pillai PS; Scott DW
J Immunol; 1984 May; 132(5):2273-8. PubMed ID: 6201539
[TBL] [Abstract][Full Text] [Related]
52. Antibody to a molecularly-defined antigen confined to a tumour cell surface.
Stevenson GT; Stevenson FK
Nature; 1975 Apr; 254(5502):714-6. PubMed ID: 47617
[No Abstract] [Full Text] [Related]
53. Chemical modification and immunogenicity of membrane fractions from mouse tumour cells.
Staab HJ; Anderer FA
Br J Cancer; 1978 Oct; 38(4):496-502. PubMed ID: 215180
[TBL] [Abstract][Full Text] [Related]
54. Rabbit antiserum against a non-T, non-B leukemia cell line that carries the Ph1 chromosome (NALM-1): antibody specific to a non-T, non-B acute lymphoblastic leukemia antigen.
Koshiba H; Minowada J; Pressman D
J Natl Cancer Inst; 1978 Oct; 61(4):987-91. PubMed ID: 81309
[TBL] [Abstract][Full Text] [Related]
55. Modulation of the immune response to transplantation antigens. II. The effects of heterologous antisera on the growth of tumour allografts in mice.
Zola H
Clin Exp Immunol; 1974 Mar; 16(3):461-7. PubMed ID: 4468850
[TBL] [Abstract][Full Text] [Related]
56. A notable phenomenon recapitulated. A fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously.
Sinkovics JG
Acta Microbiol Immunol Hung; 2005; 52(1):1-40. PubMed ID: 15957233
[TBL] [Abstract][Full Text] [Related]
57. Human cell membrane components dominant in T cell lineage: identification and characterization of human TL-like antigens.
Tanigaki N; Tokuyama H; Fukunishi T; Minowada J; Pressman D
J Immunol; 1979 Dec; 123(6):2906-14. PubMed ID: 387877
[TBL] [Abstract][Full Text] [Related]
58. Immune responses to virus induced experimental leukemia and to human leukemia.
Herberman RB
Johns Hopkins Med J Suppl; 1974; 3():3-14. PubMed ID: 4371287
[No Abstract] [Full Text] [Related]
59. Autologous human B and T lymphoblastoid cell lines.
Royston I; Smith RW; Buell DN; Huang ES; Pagano JS
Nature; 1974 Oct; 251(5477):745-6. PubMed ID: 4372538
[No Abstract] [Full Text] [Related]
60. The T cell-dependent period of the immune response to sheep erythrocytes.
Van Muiswinkel WB; Van Soest PL
Immunology; 1976 Jul; 31(1):111-8. PubMed ID: 800399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
